FEATURED CONTRIBUTED CONTENT

The Future of RWE Technology – Moving Beyond Rapid Cycle Analytics


The Future of RWE Technology – Moving Beyond Rapid Cycle Analytics

In recent years, a plethora of real-world evidence (RWE) analytic platforms have emerged, giving researchers the ability to submit analysis parameters, execute analytic programs across specific data sources, and produce rapid results without custom programming. These RWE platforms facilitate shortened analysis cycle times, delivering results in minutes or hours, instead of days, weeks, or longer. […]

August 7, 2017 More Clinical »
Early Access – Where do Payers Stand?


Early Access – Where do Payers Stand?

This article covers 5 key issues related to payers’ treatment of pricing and reimbursement. Issue 1: It is not rocket science: Less substantiated value propositions for molecules that launch with Phase II data translate into less positive benefit assessments by national agencies. Issue 2: In 2017, payers across the EU and US have shown significant […]

September 12, 2017 More Clinical »
How Big Data is Actively Impacting Healthcare


How Big Data is Actively Impacting Healthcare

Big data has become a buzzword in the industry, Cello Health’s Elizabeth, Jackie, and Kimberly predict how it will actively impact the future of healthcare, providing real world examples. From streamlining the development of new therapies, helping to drive personalized treatment decisions, and facilitating demonstration of the real-world value of pharmaceutical products, big data should […]

September 6, 2017 More Clinical »
Bhaskar Sambasivan: A Pioneer in the Shift to Digital  – a 2017 PharmaVOICE 100 Honoree


Bhaskar Sambasivan: A Pioneer in the Shift to Digital – a 2017 PharmaVOICE 100 Honoree

Bhaskar Sambasivan, Senior VP and Global Head, Life Sciences at Cognizant, believes the factors that foster innovation are empowerment and the freedom to experiment and take risks. He challenges the status quo, bringing people and partners together, to maintain growth year over year. Mr. Sambasivan makes bold bets and encourages transformational ideas among his life […]

August 14, 2017 More Clinical »
The New Reality: Maximizing Value in Rare Disease Launches


The New Reality: Maximizing Value in Rare Disease Launches

The rare disease landscape is changing: with assets being granted expedited review, launch is no longer a fixed point in time, and research and development (R&D), medical affairs, and commercial teams need to collaborate early in the process to reach critical consensus on where to focus, when to engage key health care provider (HCP) stakeholders, […]

September 7, 2017 More Clinical »
Expediting Drug Approval


Expediting Drug Approval

For patients with serious and rare diseases, time is of the essence, and the traditional drug development process may take far too long. To speed innovative new drugs to market, the FDA has established four expedited programs that allow the development process to be compressed and evidence of the drug’s effectiveness gathered as efficiently as […]

April 3, 2017 More Clinical »
Amber Eaton: Connecting passion and Conviction – a 2017 PharmaVOICE 100 Honoree


Amber Eaton: Connecting passion and Conviction – a 2017 PharmaVOICE 100 Honoree

An innovator and motivator, Amber Eaton is propelling MicroMass to new heights in its efforts to change patient and provider behavior. Ms. Eaton possesses a strong strategic vision as well as a penchant for fine details. This has served her well in her career and as VP, Group Account Director at MicroMass Communications. In her […]

September 11, 2017 More Clinical »
Al Altomari: The Caring Warrior  – a 2017 PharmaVOICE 100 Honoree


Al Altomari: The Caring Warrior – a 2017 PharmaVOICE 100 Honoree

Al Altomari, Chairman and CEO of Agile Therapeutics Inc. always seeks to always do the right thing and is selfless in his contributions to both the business and on a personal level. He seeks to inspire with passion, energy, and caring. He fosters innovation by letting people make mistakes and by laughing at his own […]

August 11, 2017 More Clinical »
Evidence Wisely: Advanced Learnings from the Field


Evidence Wisely: Advanced Learnings from the Field

In the ever-evolving healthcare landscape, stakeholders are demanding more Real-World Evidence (RWE), and more RWE is becoming available. That should mean that demand should be easy to satisfy, right? Explore this informative ebook to learn about the latest in RWE, using the ebook link below. There is also a related podcast, entitled, “The Real Value […]

May 31, 2017 More Clinical »
Beyond Compliance: Regulated Content Management and the Digital Revolution


Beyond Compliance: Regulated Content Management and the Digital Revolution

Globalization of clinical trials, tightening regulatory requirements, a more competitive and collaborative commercial environment, and an increasingly mobile workforce requires life-sciences companies to standardize and improve regulated content management processes to ensure information is shared with the right people at the right time. This paper explores issues that impact the way regulated content is managed and used and what CIOs […]

August 1, 2017 More Clinical »
Discover the Megatrends Remapping the Pharmaceutical Market


Discover the Megatrends Remapping the Pharmaceutical Market

New Manatt Health Webinar Reveals the Megatrends Reinventing the Ways Your Patient, Provider and Payer Customers Think—and How You Should Respond to Succeed. Click to Register Free. From the continued evolution of new payment models to the explosion of mHealth to the creation of personalized therapies, powerful trends and disruptive innovations are converging to reshape […]

November 14, 2017 More Clinical »
FEEDBACK